These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12963758)

  • 1. Clinical outcomes of possible versus probable Alzheimer's disease.
    Villareal DT; Grant E; Miller JP; Storandt M; McKeel DW; Morris JC
    Neurology; 2003 Sep; 61(5):661-7. PubMed ID: 12963758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    Scheltens NME; Tijms BM; Heymans MW; Rabinovici GD; Cohn-Sheehy BI; Miller BL; Kramer JH; Wolfsgruber S; Wagner M; Kornhuber J; Peters O; Scheltens P; van der Flier WM;
    J Alzheimers Dis; 2018; 65(3):1029-1039. PubMed ID: 30103316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study.
    Reisberg B; Ferris SH; Franssen EH; Shulman E; Monteiro I; Sclan SG; Steinberg G; Kluger A; Torossian C; de Leon MJ; Laska E
    Int Psychogeriatr; 1996; 8(2):291-311. PubMed ID: 8994898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia.
    Corey-Bloom J; Galasko D; Hofstetter CR; Jackson JE; Thal LJ
    J Am Geriatr Soc; 1993 Jan; 41(1):31-7. PubMed ID: 8418119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.
    Fruehwirt W; Dorffner G; Roberts S; Gerstgrasser M; Grossegger D; Schmidt R; Dal-Bianco P; Ransmayr G; Garn H; Waser M; Benke T
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():31-38. PubMed ID: 30582941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
    Agüero-Torres H; Fratiglioni L; Guo Z; Viitanen M; Winblad B
    J Am Geriatr Soc; 1998 Apr; 46(4):444-52. PubMed ID: 9560066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a Rasch scale to characterize the clinical features of patients with a clinical diagnosis of uncertain, probable, or possible Alzheimer disease at intake.
    Hughes LF; Perkins K; Wright BD; Westrick H
    J Alzheimers Dis; 2003 Oct; 5(5):367-73. PubMed ID: 14646027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia.
    Mioshi E; Flanagan E; Knopman D
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):977-982. PubMed ID: 27464599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
    Sood A; Pavlik V; Darby E; Chan W; Doody R
    J Alzheimers Dis; 2021; 80(2):735-747. PubMed ID: 33579838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study.
    Geerlings MI; Deeg DJ; Schmand B; Lindeboom J; Jonker C
    Neurology; 1997 Sep; 49(3):798-802. PubMed ID: 9305343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting time to nursing home care and death in individuals with Alzheimer disease.
    Stern Y; Tang MX; Albert MS; Brandt J; Jacobs DM; Bell K; Marder K; Sano M; Devanand D; Albert SM; Bylsma F; Tsai WY
    JAMA; 1997 Mar; 277(10):806-12. PubMed ID: 9052710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences on a brief measure of cognitive functioning in Alzheimer's disease.
    Buckwalter JG; Sobel E; Dunn ME; Diz MM; Henderson VW
    Arch Neurol; 1993 Jul; 50(7):757-60. PubMed ID: 8323481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.